SAGA Raises 40 Million SEK (€3.7 Million) To Advance Ultrasensitive Cancer Liquid Biopsies
LUND, Sweden and OSLO, Norway, June 11, 2019 / B3C newswire / -- SAGA Diagnostics AB, a precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tissues, …